Browsing: credibility

Nxera Pharma just put Q2 2026 under the microscope, and the real story is margins, not hype. The stock came into the release at ¥1,440 after a powerful 90 day climb, so expectations were loaded. Reported revenue of ¥7,654m sat against a small net loss of ¥202m, which keeps the trailing 12 month picture in…

Conversion rate optimization is much more complicated in a regulated industry like healthcare.

Reading a note or hearing a recording saying “You’re chatting with our AI assistant…” is an increasingly common part of customer service interactions. This disclosure is becoming normalized and it might read as clarity to some. But just the existence of disclosure isn’t enough to ensure a customer truly understands the role of the AI…